Monday, October 28

Care Planning: The Key to Thriving and Surviving

Monday, October 28
7:30-9:15 a.m.

Breakfast Symposium

Documenting what you do can transform your practice and attract payers. Pharmacy system vendors are making documentation and care planning easier than ever before. In this session, learn how care planning can increase your profits through direct efficiencies in your pharmacy operation and through new revenue from payers who value what you can do for patients if they see the documentation of what you’ve done.

Walk away with:

  • Real-life documentation examples resulting in a positive ROI.
  • Staff engagement strategies to integrate care planning into workflow.
  • A checklist of “low-hanging fruit” care planning interventions.

Mark McCurdy, RPh, owner, Mark’s Pharmacy. Mark is a luminary of CPESN Nebraska and one of the leaders in the nation for submitting care plans. The Mark’s Pharmacy team believes quality care means more than just prompt filling of prescriptions. This dedication to quality and patient care has led to care offerings and services that have helped establish Mark’s Pharmacy as a leader in pharmacy patient care.

Pharmacist and Pharmacy Technician Learning Objectives:

  1. Define the elements of a care plan that are needed to document patient care interactions.
  2. Describe strategies for implementing care planning into pharmacy workflow.
  3. Identify various types of interventions that should be documented in a care plan.

ACPE UAN: 0207-0000-19-315-L04-P | ACPE UAN: 0207-0000-19-315-L04-T | 1.5 contact hours (0.15 CEUs) | Activity Type: Knowledge-Based

Let’s Get Clinical: Addressing Metabolic Disease Functionally

Monday, October 28
7:45-9:15 a.m.

Breakfast Symposium

Over one-third of Americans suffer from metabolic disease according to the American Heart Association. Do you feel you have the tools needed to best help those patients? By looking at how body systems interact with one another, we will review strategies for preventing and treating metabolic disease functionally. Leave this session feeling confident in your ability to provide improved patient care and supplement recommendations for patients suffering from pre-diabetes, obesity, and adrenal dysregulation.

Walk away with:

  • Supplement recommendations that you can incorporate into your practice when working with pre-diabetic and obese patients.
  • Practical examples of how stress affects diabetic patients and how to address it.
  • Communication techniques for discussing functional medicine approaches with patients.

Melody L. Hartzler, PharmD, BCACP, BC-ADM, family medicine clinical pharmacist and associate professor of pharmacy practice, Cedarville Pharmacy. Her primary practice interests are diabetes, pulmonology, and integrative/functional medicine. Dr. Hartzler has developed an integrative medicine service in her clinical practice in family medicine and has a blog focused on incorporating this approach into chronic disease state management. She also uses her blog PharmToTable.Life as a platform to educate patients and health care providers about this practice.

Pharmacist and Pharmacy Technician Learning Objectives:

  1. Summarize the relationship between gut health and metabolic disease.
  2. Outline important supplements for consideration in diabetic and pre-diabetic populations.
  3. Identify the role of stress in diabetes and adrenal dysregulation.

 ACPE UAN: 0207-0000-19-316-L01-P | ACPE UAN: 0207-0000-19-316-L01-T | 1.5 contact hours (0.15 CEUs) | Activity Type: Knowledge-Based

Following the Yellow Brick Road to Medicaid Reform

Monday, October 28
2:45-4:15 p.m.

Want to help your patients, fill profitable prescriptions, and save your state millions (if not billions) in the process? There is no place like home (to do just that.) If it sounds too good to be true, ask the 16 states that have pulled back the proverbial rx curtain in 2019 alone to reveal PBMs pocketing millions of dollars at taxpayers’ expense. Through local relationships, community pharmacy pioneers, and government officials have turned their state’s Medicaid system on it’s head—enacting reimbursement benchmarks, demanding state Medicaid oversight, and encouraging any willing provider. They made it happen—and you can too.

Walk-away with:

  • Real-world tips for telling your story to changemakers.
  • Talking points for approaching your Medicaid department.
  • Tools to engage patients as your advocates.

Steve Moore, PharmD, owner, Condo Pharmacy. Steve never misses an opportunity to share how abusive PBM practices are impacting patient lives and his business with his community, legislatures, and press. He has been quoted in local media, industry publications, and even in the New York Times.

Eric Pachman, president, 46brooklyn. Eric formed 46brooklyn to find answers to his questions about the convoluted prescription drug supply chain and share his learnings along the way. Through analyzing U.S. drug pricing data, his company has shown millions of dollars of misuse in the Medicaid programs.

Jason Rapert, Arkansas state senator. He was influential in passing the first bill in the U.S. to permit state-level regulation of pharmacy benefit managers by the state insurance commissioner. He is a vocal proponent for state PBM regulation. Under his leadership as president of the National Council of Insurance Legislators (NCOIL), NCOIL adopted the Arkansas framework as their PBM model legislation. To date, almost a quarter of the states have introduced legislation modeled after the NCOIL bill.

Pharmacist and Pharmacy Technician Learning Objectives:

  1. Discuss components of Medicaid managed care programs and the impact on taxpayer dollars.
  2. Discuss strategies for educating legislators, Medicaid administrators, or other officials about pharmacy-related advocacy initiatives.
  3. Identify opportunities to educate patients and the community about pharmacy-related advocacy initiatives via social media.

ACPE UAN: 0207-0000-19-318-L04-P | ACPE UAN: 0207-0000-19-318-L04-T | 1.5 contact hours (0.15 CEUs) | Activity Type: Knowledge-Based

Finding Opportunity in Compounding: Compliance, Quality, and Patient Care

Monday, October 28
4:00-6:00 p.m.

(Sponsored by the International Academy of Compounding Pharmacists with support from PCCA)

Part A: Smaller-Volume Compounding and Compliance: A Value Proposition for Indie Pharmacies

Compounding presents patient care and revenue opportunities for independent pharmacies, but also requires learning a new set of skills – including data collection, quality control/quality assurance, and justifying the quality of the preparations you provide. For those who understand the standards and are able to navigate the regulatory landscape, there’s a competitive advantage to be seized. This session will focus specifically on non-sterile compounding standards and the practical ways independent pharmacies can comply…profitably.

Seth DePasquale, PharmD, co-owner of BET Pharm, LLC (a compounding pharmacy specializing hormone formulations for equine reproduction.) Seth’s pharmacy ships to all 50 states, so he has a deep understanding of standards, rules, and regulations related to pharmaceutical compounding.

Dylan Herr, quality assurance and regulatory affairs manager, Eagle Analytics. Dylan oversees Eagle’s Quality Assurance and Quality Control functions of Eagle’s operations and is a regulatory consultant to 503A compounding pharmacies. Dylan has led pharmacies through NABP, BOP, and FDA inspections and helped them achieve ACHC and PCAB accreditation.

Part B: Everything Smaller-Volume Compounders Need to Know About USP <800> But Haven’t Had Time to Ask 

The evolving regulatory environment will have to make changes, from facilities to workflow to SOPs. USP <800> implementation begins December 1, so pharmacies that compound hazardous drugs need to understand the requirements, construction and other associated costs, plus best practices – even if your state has not yet implemented the chapter. In this session, you’ll learn about industry trends, what other independent compounding pharmacies have done to prepare, and strategies to help overcome the related expenses – and you’ll get risk assessment templates and other tools to help you comply!

A.J. Day, PharmD, clinical pharmacist and vice president of clinical services, PCCA. His practice focus areas include veterinary compounding, aseptic compounding, pain management, compounding technique, and regulatory affairs. A.J. serves on the IACP Board of Directors and the National Community Pharmacists Association Compounding Expert Committee.

Bryan Prescott, PharmD, MBA, director of business coaching, PCCA. He works to provide clients financial analysis, marketing, and human resource expertise. Before joining PCCA, Bryan was PIC and operations manager of LTC at Pharmcare in Pearland, Texas. He is a frequent presenter on pain, palliative care, wound, scar, ENT, and marketing.

Pharmacist and Pharmacy Technician Learning Objectives:

  1. Describe applicable USP Standards related to non-sterile compounding (not only USP <795>.)
  2. Identify three opportunities for small scale non-sterile compounding operations that are often overlooked and three skills that are necessary for compounding professionals to have.
  3. Describe the lab design requirements necessary to ensure pharmacies are compliant with USP <800>.
  4. Explain risk assessment strategies and best practices each pharmacy should follow.

ACPE UAN: 0207-0000-19-319-L07-P | ACPE UAN: 0207-0000-19-319-L07-T | 2.0 contact hours (0.2 CEUs) | Activity Type: Knowledge-Based